Trials / Unknown
UnknownNCT04523285
A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics
A Phase I, Open-label, Dose Escalation and Expansion Study to Evaluate the Tolerance, and Pharmacokinetics of TQB3728 Tablets
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a open-label, phase I study to evaluate tolerance and pharmacokinetics of TQB3728 tablets in subjects with advanced solid tumor or hematologic tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQB3728 | TQB3728 tablets is a small molecule oral drug. |
Timeline
- Start date
- 2020-10-26
- Primary completion
- 2021-12-31
- Completion
- 2022-05-30
- First posted
- 2020-08-21
- Last updated
- 2020-12-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04523285. Inclusion in this directory is not an endorsement.